Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

Taro-Rivaroxaban, Tablets
« Back to list view

Product Information

  • DIN:
    02526786
  • Active Ingredients :
    Rivaroxaban
  • Innovator Name:
    Xarelto®
  • Category:
    Anti-coagulant
  • Dosage form:
    Tablets
  • Strength:
    2.5 mg
  • Route of Administration:
    Oral
  • Package size:
    100 Bottle
  • UPC Code:
    063691101739
  • Description :
    2.5 mg Tablets: Light yellow, film-coated, round, biconvex, immediate release tablets for oral use. On one side debossed with “□” and “2.5” on the other side.
  • Non-medicinal ingredients :
    Croscarmellose sodium, low-substituted hydroxyl propyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. 2.5 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow, Iron Oxide Black. Light Yellow, film coated, round tablets. 10 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow FD&C Blue No. 1
Taro-Rivaroxaban, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02483815
  • Active Ingredients :
    Rivaroxaban
  • Innovator Name:
    Xarelto®
  • Category:
    Anti-coagulant
  • Dosage form:
    Tablets
  • Strength:
    10mg
  • Route of Administration:
    Oral
  • Package size:
    50 Bottle
  • UPC Code:
    063691082397
  • Description :
    10 mg Tablets: Pink, film coated, round, biconvex, immediate release tablets for oral use. On one side debossed with "□" and "10" on the other side.
  • Non-medicinal ingredients :
    Croscarmellose sodium, low-substituted hydroxyl propyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. 2.5 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow, Iron Oxide Black. Light Yellow, film coated, round tablets. 10 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow FD&C Blue No. 1
Taro-Rivaroxaban, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02483807
  • Active Ingredients :
    Rivaroxaban
  • Innovator Name:
    Xarelto®
  • Category:
    Anti-coagulant
  • Dosage form:
    Tablets
  • Strength:
    15 mg
  • Route of Administration:
    Oral
  • Package size:
    90 Bottle
  • UPC Code:
    063691082410
  • Description :
    15 mg Tablets: Red, film coated, round tablets, biconvex, immediate release tablets for oral use. On one side de bossed with "□" and "15" on the other side.
  • Non-medicinal ingredients :
    Croscarmellose sodium, low-substituted hydroxyl propyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. 2.5 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow, Iron Oxide Black. Light Yellow, film coated, round tablets. 10 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow FD&C Blue No. 1
Taro-Rivaroxaban, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02483823
  • Active Ingredients :
    Rivaroxaban
  • Innovator Name:
    Xarelto®
  • Category:
    Anti-coagulant
  • Dosage form:
    Tablets
  • Strength:
    20 mg
  • Route of Administration:
    Oral
  • Package size:
    90 Bottle
  • UPC Code:
    063691082403
  • Description :
    20 mg Tablets: Dark red, film coated, round, biconvex, immediate release tablets for oral use. On one side debossed with "□" and "20" on the other side.
  • Non-medicinal ingredients :
    Croscarmellose sodium, low-substituted hydroxyl propyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. 2.5 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow, Iron Oxide Black. Light Yellow, film coated, round tablets. 10 mg tablet coating: Hypromellose 2910 (HPMC), Lactose Monohydrate, Macrogol/PEG 3350, Titanium dioxide, Iron Oxide Yellow FD&C Blue No. 1
Taro-Rivaroxaban, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement